文献速递炎症性肠病

粪菌移植治疗儿童艰难梭菌感染的疗效

Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-04-19

该多中心回顾性队列研究纳入2004年2月1日至2017年2月28日18个儿科中心372例11月龄至23岁接受粪菌移植(FMT)治疗艰难梭菌感染(CDI)的患者,335例有2个月随访数据,单次FMT后81%无复发,首次或重复FMT后86.6%无复发。使用新鲜供体粪便、经结肠镜途径、无喂养管及FMT前CDI发作次数较少与FMT成功相关。

要点

  • 335例中有271例(81%)单次FMT后2个月内无CDI复发。
  • 新鲜供体粪便、结肠镜途径、无喂养管及FMT前CDI发作少与成功相关。
  • 17例(4.7%)在3个月随访期内发生严重不良事件,包括10例住院。

核心结论

  • 基于大型多中心回顾性队列,FMT治疗儿童和年轻成人CDI有效且安全。
  • 需进一步研究以优化儿科患者FMT的时机和方法,与成功相关的因素与成人患者不同。

研究设计与样本

  • 多中心回顾性队列研究,纳入18个儿科中心2004年2月1日至2017年2月28日接受FMT的372例11月龄至23岁患者,335例有2个月结局数据。
  • FMT成功定义为FMT后2个月内无CDI复发,采用逐步逻辑回归识别与成功相关的因素。

主要发现

  • 335例中271例(81%)单次FMT后成功,86.6%在首次或重复FMT后成功。
  • 使用新鲜供体粪便者成功比值比OR 2.66(95%CI 1.39-5.08)。
  • 经结肠镜途径FMT者OR 2.41(95%CI 1.26-4.61)。
  • 无喂养管者OR 2.08(95%CI 1.05-4.11)。
  • FMT前CDI发作次数少1次者OR 1.20(95%CI 1.04-1.39)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Fecal microbiota transplantation (FMT) is commonly used to treat Clostridium difficile infection (CDI). CDI is an increasing cause of diarrheal illness in pediatric patients, but the effects of FMT have not been well studied in children. We performed a multi-center retrospective cohort study of pediatric and young adult patients to evaluate the efficacy, safety, and factors associated with a successful FMT for the treatment of CDI. METHODS: We performed a retrospective study of 372 patients, 11 months to 23 years old, who underwent FMT at 18 pediatric centers, from February 1, 2004, to February 28, 2017; 2-month outcome data were available from 335 patients. Successful FMT was defined as no recurrence of CDI in the 2 months following FMT. We performed stepwise logistic regression to identify factors associated with successful FMT. RESULTS: Of 335 patients who underwent FMT and were followed for 2 months or more, 271 (81%) had a successful outcome following a single FMT and 86.6% had a successful outcome following a first or repeated FMT. Patients who received FMT with fresh donor stool (odds ratio [OR], 2.66; 95% CI, 1.39-5.08), underwent FMT via colonoscopy (OR, 2.41; 95% CI, 1.26-4.61), did not have a feeding tube (OR, 2.08; 95% CI, 1.05-4.11), or had 1 less episode of CDI before FMT (OR, 1.20; 95% CI, 1.04-1.39) had increased odds for successful FMT. Seventeen patients (4.7%) had a severe adverse event during the 3-month follow-up period, including 10 hospitalizations. CONCLUSIONS: Based on the findings from a large multi-center retrospective cohort, FMT is effective and safe for the treatment of CDI in children and young adults. Further studies are required to optimize the timing and method of FMT for pediatric patients-factors associated with success differ from those of adult patients.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Nicholson MR, Mitchell PD, Alexander E, et al. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. Clin Gastroenterol Hepatol. 2019. PMID: 31009795. doi:10.1016/j.cgh.2019.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。